*Dr. D. Mahesh Rahul MBBS and Dr. R. Sri Sruthi MBBS


Introduction: Urinary tract infection (UTI) is one of the most prevalent diseases affecting people of all age groups i.e. from neonate to geriatric age group. This is a problem that has got a big share in health care costs taking both community acquired and hospital acquired urinary tract infections into consideration. The present study aims to throw light on the age wise prevalence of urinary tract infections, possible steps to be explained to the patient to avoid contracting UTI, early diagnosis, planning a workup if necessary and treatment of urinary tract infections in our scenario. Materials and Methods: The present study is a retrospective analysis of culture results of urine samples, conducted at various laboratories in and around ELURU and VIJAYAWADA, ANDHRA PRADESH for suspected UTI in patients visiting outpatient departments and hospitalised patients of various hospitals. The age & sex of patients, the organism isolated and also the antimicrobial susceptibility & resistance profiles, were collected from the laboratory registers using a standard data collection form. Results: The overall prevalence of UTI was 34.56% of which 68.78% were females and 31.22% were males. E.coli (64.77%) was the commonest isolate causing UTI, especially in community acquired infections followed by Klebsiella pneumoniae (22.40%). The most effective antimicrobial agents in our study were Meropenem, Gentamicin, Nitrofurantoin and Cotrimoxazole. Antibiotics being emperically used, for example, Fluoroquinolones, Amoxicillin and Cephalosporins were often found to be very less effective, especially in Health Care Assosciated UTI. Cotrimoxazole, probably because of its decreased use in clinical practice now a days has started regaining its potential against uropathogens. Conclusion: UTI, which is a very common illness, has to be understood in a holistic manner, to help the patients in a better way.

Keywords: Urinary tract infection, Prevalence, Uropathogens.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tanima Debnath Sarkar

Download Article : Click here

News & Updation


    OCTOBER 2021 Issue has been successfully launched on 1 October 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction